Skip to main content
Virologica Sinica logoLink to Virologica Sinica
. 2012 Jun 9;27(3):187–193. doi: 10.1007/s12250-012-3247-8

Comparison of RFFIT tests with different standard sera and testing procedures

Peng-cheng Yu 1, Akira Noguchi 2, Satoshi Inoue 2, Qing Tang 1,, Simon Rayner 3, Guo-dong Liang 1
PMCID: PMC8218074  PMID: 22684473

Abstract

The World Health Organization (WHO) standard assay for determining antibody level is the rapid fluorescent focus inhibition test (RFFIT) and is used to determine the degree of immunity after vaccination against rabies. To compare the difference in RFFIT results between the laboratories of The National Institute of Infectious Disease in Japan (NIID) and the Chinese Centre for Disease Control (CCDC) as well the influence of the choice of standard serum (STD) for the detection, the two laboratories detection methods were simultaneously manipulated by RFFIT. The reference serums used in NIID and the WHO standard serum used in CCDC were compared in the same RFFIT detection to determine the titer of four sera samples C1, S1, S2 and S4 in parallel, and the titers of the detected sera samples were calculated using the standard formula for neutralizing antibody titer. No significant difference was found in RFFIT methods from the two laboratories and the RFFIT testing procedures of the two laboratories have good consistency. However, different titers were obtained with the tentative internal standard serum (TI-STD) produced by adjusting to 2.0 IU of WHO standard serum in NIID and the WHO STD. The titer determined with the TI-STD was higher than that determined with WHO STD, This difference appears to be significant and requires further investigation.

Key words: Rapid fluorescent focus inhibition test (RFFIT), Standard serum, Neutralizing antibody, Titer

Footnotes

Foundation items: Grant from National Institute of Infectious Diseases(NIID); National Department Public Benefit Research Foundation (201103032).

References

  • 1.WHO. WHO Expert Consultation on Rabies. Geneva: World Health Organization; 2005. [PubMed] [Google Scholar]
  • 2.Wu X. H., Li J., et al. Development of Serum Series References of RFFIT for Assessment of Rabies Neutralizing Antibody. Chin Pharm Aff. 2011;24(11):1082–1084. [Google Scholar]
  • 3.Yan J. X., Li C. P., et al. Establishment of the rapid fluorescent focus inhibition test (RFFIT) for the detection of rabies virus neutralizing antibodies. Chin J Biol. 1998;11(2):93–96. [Google Scholar]
  • 4.Yu P. C., Lv X. J., et al. The establishment of a rapid fluorescent focus inhibition test for testing rabies virus neutralizing antibody. Chin J Epid. 2010;31(4):438–441. [PubMed] [Google Scholar]
  • 5.Yu P. C., She X. X., et al. The comparison of the WHO standard rabies immunoglobulin and the national standard human rabies immunoglobulin used in the rapid fluorescent focus inhibition test (RFFIT) Chin J Exp Clin Virol. 2010;24(2):91–93. [PubMed] [Google Scholar]
  • 6.Yu Y. X. Development and current situation of domestic and foreign rabies vaccine. Shanghai J Prev Med. 2006;18:216–218. [Google Scholar]

Articles from Virologica Sinica are provided here courtesy of Wuhan Institute of Virology, Chinese Academy of Sciences

RESOURCES